Ok Terry. There's a patent on iplex, and you are saying it's worthless. How did you determine it was worthless and it has no market value. Intellectually, are you capable of discerning the value of something in which you have no intimate knowledge. Tell us how you derive the worth of patents in the biotech arena. Schmuck!
Sweden's Cortendo--which has a diabetes-focused subsidiary--got a new CEO this week, with former Shire executive Matthew Pauls starting at the company. Pauls has a full agenda. Cortendo is planning to go public in the fourth quarter and is trying to make up time in a Phase III trial. From Fierce Biotech
Terry. You might consider joining a night trade school and taking English as a second language. It won't interfere with your Surf's up stupid chant BS. Truth is not synonymous with Terry.
I was under the impression Merck sold it off, or closed it. Last time I checked, it didn't show up as a facility operated by Merck. Google Merck and Boulder plant, and nothing turned up.
I wonder if Terry sold Steve Cohen his 10 shares. Makes you also wonder if Cohen has been taking Terry's investment advice. How could he go wrong!
jad, I don't know if it was you or rook who put up the questions earlier today, but it appears they are all gone from the message board. I didn't have time to read them all, but was hoping to now.
kvmncdd = one of Terry's clone jobs. If, according to your opinion "We (Terry and his IDs) have to admit Insmed is a high risk stock to own for a long time.", why do you own, and why do you care if others own this stock?
With so many IDs, he needs a magnetic bulletin board to keep his flow chart accurate as to what ID he has used.
Let's see. Terry_Insmed writes " YTD up 175%". Then ID # (pick one) say Terry's the best trader whenever he comes back from vacation, or when he returns from "Surfs Up". Truly a legend in his own mind, and a Loser in mine!
I don't see where $7 = $12.66, or where $12.66 = 51. Terry's a great armchair quarterback where hindsight is 20/20, as well as his multiple IDs.
Jad. It seems that Lewis and management had put together a fairly decent timeline for Commercial launch in the last several Investor presentations, as they had listed 2015 and 2016 as the timeline for possible Commercial Launch. So, EMA said yes to go ahead and apply, and FDA said wait, and do an abbreviated trial that continues off of a previous Phase 2 trial. Now we know the timelines, which we didn't know last week. I don't think too many are surprised about the FDA decision, even though there was some hope. But the EMA puts us on the planned path for approval for CF and now, with the addition for NTM, offers a broader opportunity for the all the patients afflicted with their disease. Let the shorts have their day or weeks, but they know the risk is greater for them as we approach 2015. Clearly, a buying opportunity for those who can see through the smoke.
Jad. One of the ironies of Terry, is he calls message board posters "girls". I'm sure that the "masculinity" he desires should be to post under one name where he can stand for whatever position he wants to take on a stock, negative or positive. But to spend the time he does to deceive people with all the different IDs, lies, & distortions really isn't very masculine, but makes him look like a "pathetic" loser. Too bad he doesn't have the mental ability to grasp that concept.
Jad. It seems to me if I was an institution, hedge fund, or trader and I didn't care too much about proper transaction procedures, and I located a stock I really liked that had great potential, how would I go aout finding shares when over 80% are institution controlled? Would I buy at the market everyday? Would I buy at price points I liked? Would I set parameters for the day, and try and bring the SP down every day, and pick off shares on the way back up. Would I short the stock on one hand, and play the trading range, and make the percentages I wanted on a daily or weekly basis. If there is no news for a period of time, several weeks on end, this would be an excellent way to grab shares, or make money as it trades up or down. It seems that is the pattern Insmed is in, and will change when news is announced that is favorable to Insmed.
You would think a company that was looking to hire a CMO would have a job opening posted for one. Or announced that they hired one.
Actually Dave, Terry is a Superhero. His superpower is his ability to lie, distort, and make up BS without providing any facts. He said he was an engineer, but I think he was a politician previously.